Sustained release of epigallocatechin gallate from calcium carbonate nanoparticles: promising therapy for colorectal cancer
- 15 May 2025
- journal article
- research article
- Published by Springer Nature in Applied Nanoscience
- Vol. 15 (3) , 1-12
Abstract
No abstract availableKeywords
Funding Information
- UGC-DAE Consortium for Scientific Research, University Grants Commission
This publication has 24 references indexed in Scilit:
- Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future successAdvances in Cancer Biology - Metastasis, 2024
- "Cholinergic side Effect-Free anticancer drugs: paving the way for safer and more effective cancer treatment"Journal of Biomolecular Structure and Dynamics, 2023
- Smart Nanomaterials in Cancer Theranostics: Challenges and OpportunitiesACS Omega, 2023
- Recent Advances in Calcium‐Based Anticancer Nanomaterials Exploiting Calcium Overload to Trigger Cell ApoptosisAdvanced Functional Materials, 2022
- Connecting Calcium-Based Nanomaterials and Cancer: From Diagnosis to TherapyNano-Micro Letters, 2022
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeuticsGenes & Diseases, 2022
- Colorectal cancer—global burden, trends, and geographical variationsJournal of Surgical Oncology, 2017
- Anticancer effects and molecular mechanisms of epigallocatechin-3-gallateIntegrative Medicine Research, 2014
- The causes and consequences of genetic heterogeneity in cancer evolutionNature, 2013
- The Spread of Rectal Cancer and its Effect on PrognosisBritish Journal of Cancer, 1958